Connecting the community: Social media used for panel discussion

Article

A Corporate Social Responsibility (CSR) panel discussion will be held by the International Agency for the prevention of Blindness (IAPB) solely via social networking.

A Corporate Social Responsibility (CSR) panel discussion will be held by the International Agency for the prevention of Blindness (IAPB) solely via social networking.

Everyone in the ophthalmic community is encouraged to submit questions via Facebook, Twitter and email. International industry leaders will then answer the questions and offer suitable advice.

The CSR panellists include Caroline Roan, president of the Pfizer foundation, Alcon’s Strategic Markets Medical Director in Asia, Dr Hunter Cherwek and Claude Darnault, Chief Sustainability Officer at Essilor in France.

Phillip Albano, Coordinator of the CSR panel stated, "Whether it’s providing financial or in-kind support, CSR plays a critical role in national eye care systems. Less understood though is the considerations businesses take into account before entering into private/public partnerships. During the symposium, leaders in the field will explore the theory and practice of CSR, highlight key public/private partnerships and discuss ways in which the private sector, governments, NGOs and others might partner more effectively in the future."

To register or found out more information on the IAPB please visit www.9ga.iapb.org

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.